Lazertinib
About
Therapy type: Targeted therapy
Therapy strategy: EGFR inhibition
Mappings
NCI Thesaurus: Lazertinib (coding:ncit:C148147)
RxNorm: lazertinib (coding:rxcui:2691150, coding:omop:1735080)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (2) HC (1) | EGFR Exon 19 (Deletion) | Non-Small Cell Lung Cancer | Amivantamab, Lazertinib | |
| FDA (2) HC (1) | EGFR p.L858R | Non-Small Cell Lung Cancer | Amivantamab, Lazertinib |